ASH 2022 | Real-world analysis of treatment patterns & outcomes for follicular lymphoma in the US

Tycel Phillips, MD, City of Hope, Duarte, CA, describes the results of a real-world analysis examinating treatment patterns and outcomes in patients with follicular lymphoma (FL) over time in the US. Dr Phillips explains that outcomes with second-line treatment were superior compared to third-line treatment and beyond. Furthermore, while novel targeted agents were found to be used for second-line and third-line treatment, the analysis showed that these agents are not being used as often as would be expected given how many new therapies have been approved. Dr Phillips therefore suggests that treating physicians be educated on and encouraged to use these novel drugs as these will likely improve the outcomes of patients undergoing multiple lines of treatment. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.